• 52,741+ CME Conference Registrations Sold
  • 158,223+ Medical Conferences
  • 285 Specialties
  • 11,425 Organizers
  • 157,142 Speakers
  • 159 Countries
  • 4,803 Cities
Home  >  Speakers  >  Sergio Fazio
Sergio Fazio

Sergio Fazio

    MD, PhD
Chair, Director, Professor | Portland, Oregon    United States of America
Cardiology, Endocrinology, Metabolism And Diabetes
Update In Hyperlipidemia ATP 2014: What’s Bad Abo Lipid Management,...More
Spoken at 11 events
Speaking at 1 event

Biography :

A graduate of the medical school of the University of Rome, Italy, Dr. Fazio continued at the same institution with a fellowship in Metabolic Diseases. In 1985, he undertook a Ph.D. program in Experimental Medicine at the University of Siena, Italy, and completed it at the University of California, San Francisco (UCSF). In 1988 Dr. Fazio joined the Gladstone Institute of Cardiovascular Disease, UCSF, as a postdoctoral scientist first, and then as a staff scientist (Instructor in Medicine, UCSF).

In 1993 Dr. Fazio joined the faculty of the School of Medicine at Vanderbilt University as an Assistant Professor in the Division of Endocrinology and Diabetes. There, he co-founded the Vanderbilt Lipid Clinic and became Director of the Vanderbilt Lipid Laboratory. He was promoted to the rank of Associate Professor in July 1998. In November of 1999, Dr. Fazio joined the Division of Cardiovascular Medicine to become the co-Director of the Atherosclerosis Research Unit. He was promoted to Professor in November 2002. In 2011 he was appointed the Cornelius Vanderbilt Chair of Cardiovascular Medicine and Chief of the section of Cardiovascular Disease Prevention. Since July 2014 he holds the William and Sonja Connor chair of Preventive Cardiology at the KCVI of OHSU.

His clinical interest is the management of dyslipidemia patients. He participates in clinical trials to study the effectiveness and efficacy of lipid-lowering drugs, and to identify mutations causing altered lipid levels in humans. Dr. Fazio’s NIH-supported research portfolio focuses on the pathogenesis of genetic dyslipidemias, the early cellular events in atherogenesis and gene therapy approaches to atherosclerosis.

*** ********
For speaker's contact information - Contact us


Cardiology, Endocrinology, Metabolism and Diabetes

Interested Topics

Update in Hyperlipidemia ATP 2014: Whats Bad About the Guidelines, Lipid Management, Endocrinology, Diabetes, Heart Disease, Diabetes, Hypertension, Lipidology, Preventive Cardiology, Management of Dyslipidemia, Atherosclerosis

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.


English, Italian

Send Message

Live to Virtual Conference

Market your online event to Million plus Healthcare professionals.